Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Bioinform.

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1093/bioinformatics/btn610PMID 19073586PMCID PMC2639011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Baseline Correction for NMR Spectroscopic Metabolomics Data Analysis

  2008cited by this paper
• Glycomics analysis of serum: a potential new biomarker for ovarian cancer?

  2007cited by this paper
• Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer.

  2006cited by this paper
• Accurate mass measurements by Fourier transform mass spectrometry

  2005cited by this paper
• Application of Fourier transform ion cyclotron resonance mass spectrometry to oligosaccharides.

  2005cited by this paper
• Correcting common errors in identifying cancer-specific serum peptide signatures.

  2005cited by this paper
• On the Role of Cell Surface Carbohydrates and their Binding Proteins (lectins) in Tumor Metastasis

  2004cited by this paper
• Mucins in cancer: protection and control of the cell surface

  2004cited by this paper
• Mass Spectrometry Basics

  2002cited by this paper
• N-glycolylneuraminic acid deficiency in humans.

  2001cited by this paper
• N-Glycolylneuraminic acid in human tumours.

  2001cited by this paper
• Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.

  2001cited by this paper
• Biosynthesis of the cancer-related sialyl-α2,6-lactosaminyl epitope in colon cancer cell lines expressing β-galactoside α2,6-sialyltransferase under a constitutive promoter

  2001influential reference
• Pathways of O-glycan biosynthesis in cancer cells.

  1999cited by this paper
• Protein glycosylation in development and disease

  1999cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995influential reference
• Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases.

  1987cited by this paper

• Detection of Protein and Metabolites in Cancer Analyses by MALDI 2000–2025

  2025cites this paper
• A Guide to MALDI Imaging Mass Spectrometry for Tissues.

  2023cites this paper
• Quantitative Glycomics: A Combined Analytical and Bioinformatics Approach.

  2017cites this paper
• Quantitative profiling of glycans and glycopeptides: an informatics' perspective.

  2016cites this paper
• Analytical detection and characterization of biopharmaceutical glycosylation by MS.

  2016cites this paper
• Glycosylation characteristics of colorectal cancer.

  2015cites this paper
• Spatially-resolved exploration of the mouse brain glycome by tissue glyco-capture (TGC) and nano-LC/MS.

  2015cites this paper
• Statistical detection of quantitative protein biomarkers provides insights into signaling networks deregulated in acute myeloid leukemia

  2014cites this paper
• Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2009–2010

  2014cites this paper
• GlyQ-IQ: Glycomics Quintavariate-Informed Quantification with High-Performance Computing and GlycoGrid 4D Visualization

  2014cites this paper
• Quantitative Glycomics by Mass Spectrometry and Liquid Chromatography-Mass Spectrometry

  2014cites this paper
• New strategies for resolving oligosaccharide isomers by exploiting mechanistic and thermochemical aspects of fragment ion formation.

  2013cites this paper
• Serum Glycan Signatures of Gastric Cancer

  2013influential citation
• Mass Spectrometry of Glycoproteins

  2013cites this paper
• Bioinformatic analysis of data generated from MALDI mass spectrometry for biomarker discovery.

  2013influential citation
• Label‐free relative quantification of alpha‐2‐macroglobulin site‐specific core‐fucosylation in pancreatic cancer by LC‐MS/MS

  2013cites this paper
• Applications of Mass Spectrometric Assays for Analysis of Serum Protein N-glycosylation Associated with Pancreatic Cancer

  2013cites this paper
• Elucidation of N-glycosites within human plasma glycoproteins for cancer biomarker discovery.

  2013cites this paper
• Glycomics: an overview of the complex glycocode.

  2012cites this paper
• Reproducibility of mass spectrometry based protein profiles for diagnosis of ovarian cancer across clinical studies: A systematic review.

  2012influential citation
• Improve accuracy and sensibility in glycan structure prediction by matching glycan isotope abundance.

  2012cites this paper
• The glycolyzer: Automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery

  2012cites this paper
• Glycoscience aids in biomarker discovery.

  2012cites this paper
• Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer.

  2011cites this paper
• Development of a Matrix-prespotted Plate for Enhancing the Reproducibility of Serum Glycan Analysis by MALDI-TOF-MS

  2011cites this paper
• Mass spectrometry of peptides and proteins from human blood.

  2011cites this paper
• New technologies for glycomic analysis: toward a systematic understanding of the glycome.

  2011cites this paper
• Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling.

  2010cites this paper
• Sweetening the pot: adding glycosylation to the biomarker discovery equation.

  2010cites this paper
• Glycome profiling using modern glycomics technology: technical aspects and applications

  2010cites this paper
• The effects of abundant plasma protein depletion on global glycan profiling using NanoLC FT-ICR mass spectrometry

  2010cites this paper
• Glycomic analysis of ovarian cancer: Past, present, and future

  2010cites this paper
• A general-purpose baseline estimation algorithm for spectroscopic data.

  2010cites this paper
• A glycomics approach to the discovery of potential cancer biomarkers.

  2010cites this paper
• Analysis of MALDI FT-ICR mass spectrometry data: a time series approach.

  2009cites this paper
• Glycomic analysis: an array of technologies.

  2009cites this paper